Back to today’s briefing

Story perspectives

Drugmakers Slam U.S. Tariffs, China Condemns Trade Tactics

5/30/2025

48 11

Summary

Story summary

Drugmakers and trade groups oppose U.S. tariffs on pharmaceutical imports due to high reshoring costs.
The EU highlighted its strong trade ties, with 38% of its pharmaceutical exports going to the U.S.
China condemned the U.S. for using national security as a rationale for tariffs, claiming it jeopardizes trade agreements.

1 of 1

Story summary

Drugmakers and trade groups oppose U.S. tariffs on pharmaceutical imports due to high reshoring costs.
The EU highlighted its strong trade ties, with 38% of its pharmaceutical exports going to the U.S.
China condemned the U.S. for using national security as a rationale for tariffs, claiming it jeopardizes trade agreements.